Biologic drugs transformed the treatment of cancer, autoimmune disease, and diabetes, but their cost has kept many patients and health systems from benefiting fully. Biosimilars are changing that. They offer comparable safety, purity, and efficacy at a lower price, and they are now one of the fastest-growing segments in pharmaceuticals.
Here is how the global market is performing, how it breaks...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek